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Is chronic low back pain and radicular neuropathic pain associated 
with smoking and a higher nicotine dependence? A cross-sectional 
study using the DN4 and the Fagerström test for nicotine dependence
Kronik bel ağrısı ve radiküler nöropatik ağrı, sigara içme ve daha yüksek nikotin bağımlılığı ile 
ilişkili midir? Nikotin bağımlılığı için DN4 ve Fagerström testinin kullanıldığı kesitsel bir çalışma




Objectives: To evaluate, if a current smoking status and a higher nicotine dependence were associated with chronic low back pain 
(LBP) and/or radicular neuropathic leg pain.
Methods: The study was designed as a cross-sectional study on the first eligible consecutive 120 patients. Demographic data, pain inten-
sity, worst pain location, most distal pain radiation, the DN4 questionnaire, STarT back tool, and the Fagerström test were collected during 
the initial examination. An age- and gender-matched control group (n=50), free from chronic LBP was recruited.
Results: In the chronic pain group, there was a significant difference between smokers and lifetime non-smokers in the average pain 
intensity score (p=0.037), total DN4 score (p=0.002), STarT Back tool (p=0.006), worst pain location (p=0.023), and the most distal pain 
radiation (p=0.049). The mean total DN4 score increased with a corresponding increase in the number of cigarettes smoked daily 
(p=0.002). Current smokers had an OR of 3.071 (p=0.013) (95% CI 1.268–7.438) for developing chronic LBP and lumbar related leg 
pain and an OR of 6.484 (p<0.001) (95% CI 2.323–18.099) for developing chronic radicular neuropathic leg pain. For every one-unit 
increase in the Fagerström test score, the likelihood for chronic LBP and lumbar related leg pain increased by 40.71% (p=0.008) (95% 
CI 1.095–1.809) and for chronic radicular neuropathic leg pain increased by 71.3% (p<0.001) (95% CI 1.292–2.272).
Conclusion: A current smoking status and a nicotine dependence were both independently associated with an increased risk for 
chronic LBP and/or chronic radicular neuropathic leg pain.
Keywords: Chronic pain; cross-sectional studies; low back pain; neuralgia; nicotine; radiculopathy; sciatica; smoking; tobacco use disorder.
Özet
Amaç: Mevcut sigara içme durumunun ve yüksek nikotin bağımlılığının kronik bel ağrısı (KBA) ve/veya radiküler nöropatik ağrı ile 
ilişkili olup olmadığını değerlendirmek.
Gereç ve Yöntem: Çalışma, ilk uygun ardışık 120 hasta ile kesitsel bir çalışma olarak tasarlandı. Demografik veriler, ağrı yoğunluğu, 
en kötü ağrı konumu, en distal ağrı radyasyonu, DN4 anketi, STarT bel sağlığı tarama ölçeği ve Fagerström test sonuçları ilk muayene 
sırasında toplanmıştır. Kronik bel ağrısı olmayan, yaş ve cinsiyet uyumlu bir kontrol grubu (n=50) alındı.
Bulgular: Kronik ağrı grubunda, ortalama ağrı şiddeti skoru (p=0,037), toplam DN4 skoru (p=0,002), STarT Back ölçeği (p=0,006), en 
kötü ağrı konumu (p=0,023) ve en distal ağrı radyasyonu (p=0,049) açısından sigara içenler ve yaşam boyu sigara içmeyenler arasında 
anlamlı bir fark vardı. Ortalama toplam DN4 puanı, günlük içilen sigara sayısında karşılık gelen artışla beraber artmıştır (p=0,002). 
Mevcut sigara içenlerde KBA ve bel ile ilişkili bacak ağrısı gelişimi için OR: 3.071 (p=0,013) (%95 CI 1.268–7.438) ve kronik radiküler 
nöropatik bacak ağrısı gelişimi için OR: 6.484 (p<0,001) (%95 CI 2.323–18.099) idi. Fagerström test puanındaki her bir birimlik artış 
için, KBA ve bel ile ilişkili bacak ağrısı olasılığı %40,71 artmıştı (p=0,008) (%95 CI 1.095-1.809) ve kronik radiküler nöropatik bacak ağrısı 
olasılığı %71,3 artmıştı (p<0,001) (%95 CI 1.292–2.272).
Sonuç: Mevcut sigara içme durumu ve nikotin bağımlılığı, bağımsız olarak KBA ve/veya kronik radiküler nöropatik ağrı için artan bir 
risk ile ilişkiliydi.




Background information on the field of study
In 2016, low back pain (LBP) was one of the five lead-
ing causes of disability, causing approximately 57.6 
million years lived with disability.[1] Most patients 
who suffer from acute LBP recover within 6 weeks; 
nonetheless, symptoms persist in 5–10% of LBP suf-
ferers, with a risk of becoming chronic.[2] The tran-
sition to chronic LBP imposes a multidimensional 
burden on the person’s life with a significant im-
pact on the personal, social, and economic aspects.
[3] Amongst low back disorders, radiculopathies and 
subsequently radicular pain are considered the most
prevalent neuropathic pain condition,[4] defined by 
the International Association for the Study of Pain as 
“pain caused by a lesion or disease of the somato-
sensory nervous system.”[5] This possibly explains 
their more persistent and disabling nature as com-
pared to axial LBP,[6] evident by refractoriness to 
treatment, including strong analgesics.[7] Cigarette 
smoking is known to cause adverse effects on mul-
tiple organ systems of the body. Systematic reviews 
revealed that smoking was associated with LBP[8–10] 
and with sciatica.[11,12] Furthermore, smoking was as-
sociated with the development of various neuropa-
thies including carpal tunnel syndrome,[13] diabetic 
neuropathy,[14] ulnar neuropathy,[15] and cubital tun-
nel syndrome.[16] Importantly, the presence of such 
neuropathies is the prerequisite for the onset of neu-
ropathic pain.[4]
Smokers reported higher pain levels that neces-
sitate greater use of analgesics, with pain impact-
ing more negatively on activities of daily living.
[17] Similarly, Khan et al.[18] found that compared 
to non-smokers, current smokers suffered from a 
higher pain intensity. Furthermore, pain interfer-
ence, physical functioning, depression, and anxiety, 
all of which form part of the STarT Back tool,[19] were 
significantly (p<0.001) more prevalent in current 
smokers.[18] A search in PubMed using the terms 
“neuropathic pain and smok*” yielded a publication 
penned by Çelik et al.[20] To the authors’ best knowl-
edge, this is probably the only cross-sectional study 
dealing specifically with nicotine dependence and 
neuropathic pain, which the current authors read 
with interest. The study used the DN4 and the Fag-
erström test for Nicotine Dependence, and it found 
a significant difference (p<0.05) in the number of 
packets of cigarettes smoked per year between 
the individuals with and without neuropathic pain. 
However, the pathoanatomical etiology causing 
neuropathic pain could not be established, hence 
hindering the analysis of specific patient subgroups, 
which could be more prone to the deleterious ef-
fects of smoking on neuropathic pain. Furthermore, 
it did not specify if former smokers were included 
and accounted for in the results, and it did not con-
sider psychological factors that can potentially me-
diate both smoking habits and neuropathic pain.[17] 
This paper reports on a cross-sectional study which 
aims to investigate the association between a pop-
ulation of chronic LBP sufferers, which incorporated 
a subset of patients suffering from chronic radicular 
neuropathic pain, with nicotine dependence.
The objectives of this study were to investigate the 
following questions: 
1. Do current smokers have a higher pain intensity, 
higher DN4 score, and STarT Back scores com-
pared to lifetime non-smokers?
2. Do current smokers have an increased risk for 
chronic LBP, lumbar related leg pain (sciatica), 
and radicular neuropathic leg pain compared to 
lifetime non-smokers?
3. Does a higher nicotine dependency increase the 
risk for chronic LBP, lumbar related leg pain (sciat-
ica), and chronic radicular neuropathic leg pain?
Material and Methods
Study design and setting
The research committee at a local rehabilitation hos-
pital in Malta, Europe, approved the research method 
and ethical considerations undertaken in this study 
(04/03/2019). A signed written informed consent 
was obtained from all the participants. The study 
was designed as a cross-sectional study in which the 
principal investigator (ES) examined all the eligible 
patients who, between March and October 2019, 
attended for their initial physiotherapy assessment 
due to chronic LBP or lumbar related leg pain (sci-
atica) or chronic radicular neuropathic leg pain. For 
this study, the term LBP referred to pain arising from 
the lower thoracic margin extending distally to the 
horizontal gluteal folds, while pain in the lower limb 
comprised any location distal to the horizontal glu-
teal fold. Chronic pain was defined as pain for more 
than 3 consecutive months.[21]
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Since sciatica is a symptom rather than a diagno-
sis,[22] with noticeable variation in the diagnostic cri-
teria of what comprises sciatica,[11] the DN4 was used 
to systematically categorize lumbar related leg pain 
with a definite neuropathic pain component (posi-
tive DN4 score, ≥4) or caused solely by nociceptive 
referred pain, probably due to convergence mecha-
nisms (negative DN4 score, ≤3).
The patients were seen at the Musculoskeletal Phys-
iotherapy Outpatients Department at a local rehabil-
itation hospital in Malta, Europe. The number of cas-
es referred from the sole state acute general hospital 
in Malta during the study period determined the fi-
nal sample size (n=120) (Fig. 1), hereunder referred 
to the “chronic pain group.” An age- and gender-
matched chronic LBP and lumbar related leg pain 
(sciatica) free group, hereunder referred to the “con-
trol group,” who did not suffer from chronic LBP and 
lumbar related leg pain (sciatica) for the past year 
(n=50) were also recruited (Fig. 2). The control group 
was used as reference when calculating the odds ra-
tios for chronic LBP and radicular neuropathic pain. 
All of the patients included in this study form part 
of an ongoing observational study evaluating the 
management and outcome of patients with chronic 
spinal pain who have been referred to the Musculo-
skeletal Physiotherapy Outpatients Department at 
the local rehabilitation hospital. This paper was writ-
ten according to the STROBE statement.[23]
Participants
The criteria for eligibility within the chronic pain 
group included patients of both sexes (1) above 
18 years of age; (2) referred to the Musculoskeletal 
Physiotherapy Outpatient’s facilities for chronic LBP 
and/or lumbar related leg pain (sciatica); (3) with 
pain duration of ≥3 months; and (4) who were either 
lifetime non-smokers or current smokers.
Patients were excluded from the sample if they 
were living with a partner/relative who smoked, 
had other severe musculoskeletal pain, with known 
diabetic neuropathy or known length-dependent 
polyneuropathy, major comorbidity (e.g., malignant 
disorders or sepsis) or with pain of unknown origin, 
complex regional pain syndrome, headache, visceral 
pain, severe alcoholism or substance abuse, cogni-
tive impairment or intellectual disability, and severe 
depression or psychosis and if they were unable to 
understand or complete all of the questionnaires. 
Former smokers who, for the purpose of this study, 
Subject with chronic LBP and/or sciatic pain approached to take 
part in the study (n=142)
Confirmed eligibility and were asked for a written informed consent
Completed all the questionnaires and the physical examination






















• Consent not given (n=1)
• Did not understand/complete all the questionnaires (n=5)
• Lower limb pain not of spinal origin (n=4)
• Pain <3 months (n=2)
• Ex-smokers (n=5)
• Lived with a partner who smoked (n=5)
Figure 1. Flow diagram of the chronic pain participants in the 
study.
Subject without chronic LBP and/or low back related leg pain 
approached to take part in the study (n=59)
Confirmed eligibility and were asked for a written informed consent
Completed all the questionnaires and provided demographic data




• Did not understand or complete all the Fagerström tool (n=1)
• Lived with a partner who smoked (n=3)
Figure 2. Flow diagram of the control group in the study.
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were defined previously having engaged in smok-
ing activities but who currently have abstained from 
such practice were excluded as well. Ex-smokers 
were excluded due to evidence demonstrating that 
the deleterious effects of smoking can last up to 30 
years following cessation. Therefore, the effects can 
potentially reduce but cannot completely eliminate 
the risk of the onset of LBP.[11] Their exclusion helped 
avoid introducing confounding factors related to 
how long ago they had stopped smoking and any re-
sumption of smoking behaviors, which would com-
plicate the interpretation of the results.
The same criteria were applied to the control group 
except that they must have not complained of 
chronic LBP and/or lumbar related leg pain (sciatica) 
over the past year.
Patient-reported outcome measures
Demographics
Patient demographic data including age, gender, 
and pain chronicity (in years) were recorded.
Pain assessment
Pain intensity was assessed using three separate 
numeric pain rating scales (NRS) (0–10) for lowest, 
average and highest pain intensity, with anchors 
“no pain” and “worst thinkable pain.” The NRS was 
preferred over the visual analog scale (VAS) since 
previous data[24] showed that the mean age of our 
clinical population was 58.9±13.5 years,. Evidence 
suggests that this population could find difficulty 
in completing the visual analog scale and that this 
scale was associated with a higher frequency of in-
complete scores.[25]
The worst pain location was categorized as either 
in the low back or in the lower limb. The most distal 
pain radiation was recorded, and it was categorized 
into five sections, namely, the low back, knee level, 
upper calf, lower calf and/or ankle, and in the foot.[26]
The number of oral analgesic drug classes currently 
being used by the chronic pain group, irrespective 
of dosage and frequency, was collected using self-
reported information provided by the patient as part 
of the drug history recorded in the physiotherapy 
assessment. The five main analgesic drug classes 
included acetaminophen, non-steroidal anti-inflam-
matory drugs, gabapentinoids, antidepressants, and 
opioids. For patients taking a combination of anal-
gesic drugs, the number of current analgesic drug 
classes consumed was calculated as two or more de-
pending on the specific formulation of the medica-
tion involved.
To differentiate between neuropathic pain and no-
ciceptive pain, the English DN4 questionnaire[27] 
was administered during the initial physiotherapy 
assessment. The DN4 is one of the most sensitive 
neuropathic pain diagnostic questionnaires,[28] be-
ing highly capable of discriminating between neu-
ropathic pain and nociceptive pain.[29] The DN4 was 
validated in patients with LBP due to herniated 
discs, spinal stenosis, degenerative disc disease, de-
generative lumbar spine, spinal surgery, and lumbar 
scoliosis. A cutoff score of ≥4 in the DN4 obtained 
a sensitivity of 80% and a specificity of 92% in di-
agnosing neuropathic pain in LBP subjects.[30] Each 
patient was asked to describe his or her pain accord-
ing to the first seven neuropathic pain descriptors 
in the DN4 to calculate the DN4 Interview subscore 
(range 0–7). A sensory examination was carried out 
using a SENSELab™ Brush-05 (Somedic SenseLab 
AB, Sösdala, Sweden) to assess for hypoesthesia to 
brushing and brush allodynia, while a 5.1 g Semmes-
Weinstein monofilament (Baseline® Tactile Monofila-
ments™, Fabrication Enterprises Inc, White Plains, NY, 
USA) was used to assess hypoesthesia to fine tactile 
stimuli, as carried out in the original DN4 validation 
study.[27] Two repetitions of each of the three sensory 
tests were performed in the most painful area and 
compared to the corresponding contralateral as-
pect. In case of an inconsistent result between the 
two test repetitions, the result for the specific test-
ing modality was scored as a normal response. In pa-
tients with lumbar related leg pain but having their 
worst pain location in the low back area, the DN4 
was first scored for the low back. If the DN4 score was 
negative, the DN4 was re-administered in the pain-
ful lumbar related leg area. If the latter DN4 score 
was positive, this was used for statistical analysis. 
Each of the ten questions in the total DN4 score has 
a nominal scale with two possible responses (yes or 
no), and the total score was generated by summing 
the binary scores of all the ten items. Both the DN4 
Interview subscore and the total DN4 score were in-
cluded in the statistical analysis.
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Smoking and nicotine dependence
The Fagerström Test for Nicotine Dependence was 
initially developed by Fagerström and Schneider,[31] 
and then revised by Heatherton et al.[32] This test 
quantifies the nicotine addiction risk and consists 
of six questions with a possible total score rang-
ing from 0 to 10. A score of 0–2 indicates very low 
nicotine dependence, 3–4 low dependence, 5 me-
dium dependence, 6–7 high dependency, and 8–10 
specifies very high dependence. Item number 4 of 
this tool quantifies the number of cigarettes smoked 
per day clustered into four categories 10 or less, 
11–20, 21–30, or more than 31 cigarettes per day, 
with a higher cigarette consumption contributing to 
a higher final score on the questionnaire. The total 
Fagerström score and item number 4 of this ques-
tionnaire were included in the statistical analysis as 
two separate variables.
Outcome predictor
The STarT Back tool[19] includes treatment modifi-
able domains such as the spread of pain, disabil-
ity, and psychological factors. The STarT Back tool’s 
overall score ranges from 0 to 9, which is calculated 
by summing up all the positive responses report-
ed. The STarT Back distress subscales include fear, 
catastrophizing, depression, anxiety, and both-
ersomeness, and their scores range from 0 to 5. 
The STarT Back distress subscale can ably replace 
administering multiple unidimensional psycho-
logical measures at initial assessment as a first-line 
screening measure for psychological distress. This 
was evidenced in a secondary care physiotherapy 
outpatient setting where the individual distress 
STarT Back tool items were related to several uni-
dimensional psychological measures.[33] The brevity 
of this tool is advantageous in a busy outpatient 
department. Furthermore, both the total STarT 
Back score but notably the distress subscale scores 
predict pain intensity in an outpatient physical 
therapy setting.[34] In addition, the STarT Back tool 
predicted disability in subjects with chronic LBP,[3,35] 
in subjects attending a physiotherapy outpatient 
setting[36] and in a secondary care physiotherapy 
outpatient setting.[37] This is not surprising since the 
STarT Back Tool was designed to predict future dis-
ability in LBP subjects.[19] Both the STarT Back dis-
tress subscore and the total score were included in 
the statistical analysis.
The STarT Back tool and the Fagerström Test for Nico-
tine Dependence were administered after the clini-
cal examination, to minimize bias of the principal in-
vestigator carrying out the assessments. Participants 
were aware of the scope of the study but not of the 
content of the individual questionnaires carried out, 
hence to obtain single blinding. The patients were 
instructed to complete the questionnaires on pa-
per on their own but were allowed to ask for help 
if needed. Patients with missing data were excluded 
from participation in this study.
Control group
The participants within the control group reported 
all the above measures except those related to pain, 
since they had to be not suffering from chronic LBP 
or lumbar related leg pain for the past year.
Statistical analysis
Statistical testing and models were utilized to ana-
lyze the data, where a 0.05 level of significance was 
used for all the tests carried out. The Independent 
samples t-test was used to compare mean patient 
characteristics scores between two independent 
groups clustered by smoking status (yes, no). The 
patient characteristics included the lowest, average, 
and highest pain scores, pain chronicity, DN4 Inter-
view, and DN4 total scores, Fagerström score, STarT 
Back distress, and STarT Back total scores, age, and 
the number of analgesic drug classes consumed.
The One-Way ANOVA test was used to compare the 
mean Fagerström and total DN4 scores, both ranging 
from 0 to 10, between four categories of the number 
of cigarettes smoked daily (0–10, 11–20, 21–30, 31 or 
more). The Chi-square test was used to test the associ-
ation between two categorical variables. One of these 
variables was smoking status (yes and no), while the 
other variable was gender (male and female), worst 
pain location (lower back and lower limb), most distal 
pain radiation (lower back, knee, upper calf, and lower 
calf/ankle, foot), or DN4 score category (positive, and 
negative).
The difference of two proportion z-test was used 
to compare the percentage of patients whose 
worst pain was located in the lower limb between 
males and females and between smokers of 10 
cigarettes or less and smokers of more than 20 
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cigarettes. Multinomial regression analysis was 
used to relate a continuous dependent variable 
(DN4) to ten predictors collectively. A backward 
procedure was used to identify the parsimonious 
model, which includes solely the significant pre-
dictors. Logistic regression analysis was used to re-
late a categorical dependent variable (chronic LBP 
or chronic low back-related neuropathic leg pain) 
to four predictors, including Fagerström score, 
smoking status, age, and gender of the patient. 
The odds ratios and their 95% confidence interval 
were computed for ease of interpreting the re-
sults. All statistical analyses were performed using 




The baseline demographic and descriptive data 
of the 120 participants in the chronic pain group 
are presented in Tables 1–3. The control group was 
adequately age (p=0.944) and gender (p=0.873) 
matched to the chronic pain group. However, 
Table 1. Mean patient characteristics scores grouped by smoking status
Patient characteristics Smoking status Sample size Mean SD p
Age (years) Yes 40 57.10 11.395 0.094
  No 80 61.38 13.828 
Lowest pain score (NRS) Yes 40 2.35 2.248 0.529
  No 80 2.08 2.249 
Average pain score (NRS) Yes 40 6.15 2.282 0.037
  No 80 5.15 2.521 
Highest pain score (NRS) Yes 40 8.78 1.732 0.285
  No 80 8.44 1.566 
Pain chronicity (years) Yes 40 4.85 6.269 0.583
  No 80 5.69 8.665 
Number of analgesic drug classes consumed Yes 40 1.00 1.038 1.000
  No 80 1.00 0.981 
DN4 Interview score (range 0–7) Yes 40 2.53 1.811 0.000
  No 80 1.34 1.575 
DN4 total score (range 0–10) Yes 40 3.35 2.282 0.002
  No 80 2.05 2.104 
Fagerström score (range 0–10) Yes 40 4.33 2.269 0.000
  No 80 0.00 0.000 
STarT Back Distress score (range 0–5) Yes 40 2.73 1.261 0.037
  No 80 2.15 1.476 
STarT Back total score (range 0–9) Yes 40 5.38 1.904 0.006
  No 80 4.31 2.016
SD: Standard deviation; NRS: Numeric pain rating scales.
Table 2. Association between worst pain location and 
the current smoking status
   Smoking status  Total
   Yes No
Worst pain location
 Lower back
  Count 9 35 44
  Percentage 22.5 43.8 36.7
 Lower limb
  Count 31 45 76
  Percentage 77.5 56.3 63.3
Total
  Count 40 80 120
  Percentage 100.0 100.0 100.0
X2(1)=5.185; p=0.023.
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there was a statistically significant difference 
(p=0.01016) in the number of current smokers be-
tween the control group (14.0%) and the chronic 
pain group (33.3%).
Current smokers versus lifetime non-smokers in 
the chronic pain group
Table 1 shows that between the two groups, there 
was a significant difference in the mean pain score 
(p=0.037), mean DN4 Interview subscore (p<0.001), 
mean total DN4 score (p=0.002), mean STarT Back 
Distress subscore (p=0.037), and mean total STarT 
Back score (p=0.006). However, there were no sig-
nificant differences between the two groups in the 
other variables.
Smoking status and pain characteristics
Table 2 shows a significantly (p=0.023) larger per-
centage of the current smokers (77.5%) than non-
smokers (56.3%) reporting the lower limb as their 
worst pain location. Moreover, there was a signifi-
cantly (p=0.049) larger percentage of the current 
smokers (72.5%) than non-smokers (51.3%) report-
ing most distal pain radiation in the foot/lower 
calf/ankle (Table 3). Table 4 shows a significantly 
(p=0.005) larger percentage of current smokers 
(47.5%) than non-smokers (22.5%) who obtained a 
positive total DN4 score.
Dose-response effect
There was a significant difference in the mean to-
tal DN4 score between categories of the number 
of cigarettes smoked daily (p=0.002) (Fig. 3). Table 
5 shows that the mean Fagerström score increas-
es significantly with an increase in the number of 
cigarettes smoked daily (p<0.001) with the mean 
Fagerström score increasing from 1.73 for light 
smokers (0–10 cigarettes daily) to 7.67 for heavy 
smokers (more than 30 cigarettes daily). Compari-
son between light smokers and heavy smokers 
Table 3. Association between most distal pain radia-
tion in the lower limb and smoking status
   Smoking status  Total
   Yes No
Most distal pain radiation
 Lower back
  Count 2 20 22
  Percentage 5.0 25.0 18.3
 Knee
  Count 5 15 20
  Percentage 12.5 18.8 16.7
 Upper calf
  Count 4 4 8
  Percentage 10.0 5.0 6.7
 Lower calf/ankle
  Count 9 13 22
  Percentage 22.5 16.3 18.3
 Foot
  Count 20 28 48
  Percentage 50.0 35.0 40.0
Total
  Count 40 80 120
  Percentage 100.0 100.0 100.0
In Table 3, only 10% of the expected counts are <5, which is less than 
the threshold value of 20%, so Table 3 should remain the same. 1 cell 
(10.0%) have expected count <5. The minimum expected count is 2.67.
Table 4. Association between DN4 score categories 
and smoking status
   Smoking status  Total
   Yes No
DN4
 Positive (≥4)
  Count 19 18 37
  Percentage 47.5 22.5 30.8
 Negative (≤3) 
  Count 21 62 83
  Percentage 52.5 77.5 69.2
Total
  Count 40 80 120
  Percentage 100.0 100.0 100.0
X2(1)=7.815; p=0.005.
Table 5. Mean Fagerström scores grouped by number 
of cigarettes smoked daily
Cigarettes Sample Mean Fagerström SD 
daily smoked size score
0–10 11 1.73 1.272
11–20 17 4.35 1.412
21–30 9 6.33 1.000
31 or more 3 7.67 0.577
SD: Standard deviation; F(3, 36)=30.47; p<0.001.
8
PAINA RI
across the ten outcome variables was conducted. 
Except for the Fagerström score (p=0.026), the dif-
ferences in the mean scores of the other variables 
were not significant.
Relationship between the presence of 
neuropathic pain and patient characteristics
Regression analysis was used to relate DN4 score to 
ten outcome variables, which was adjusted for age, 
gender, average pain intensity, STarT Back distress 
and total scores, Fagerström score and the num-
ber of cigarettes consumed daily. Using a back-
ward procedure, Table 6 shows the four significant 
predictors of chronic radicular neuropathic pain, 
which included lower limb as worst pain location 
(p=0.035), the foot as the most distal pain radia-
tion location (p=0.001), the total STarT Back score 
(p=0.013), and the Fagerström score (p=0.014).
Current smoking status and nicotine 
dependence as risk factors for chronic LBP and 
chronic radicular neuropathic leg pain
Current smoker status
The OR that a current smoker has chronic LBP, includ-
ing lumbar related leg pain (sciatica), rather than 
being pain-free was 3.071 times (p=0.013, 95% CI, 
1.268–7.438) that of a lifetime non-smoker. The odds 
that a current smoker has chronic radicular neuro-
pathic leg pain (positive DN4 score) rather than be-
ing pain-free, is 6.484 times (p<0.001, 95% CI, 2.323–
18.099) that of a lifetime non-smoker.
Nicotine dependence- Fagerström score
For every 1 unit increase in the Fagerström score, the 
odds that a patient has chronic LBP, including lumbar 
related leg pain (sciatica), rather than being pain-free 
increases by 40.7% (p=0.008, 95% CI, 1.095–1.809). 
For every 1 unit increase in the Fagerström score, 
the odds that a patient has chronic radicular neuro-
pathic leg pain (DN4 positive score) rather than be-
ing pain-free increases by 71.3% (p<0.001, 95% CI, 
1.292–2.272).
Discussion
This cross-sectional study showed that a mean high-
er DN4 score, in participants suffering from chronic 
LBP with or without lumbar relate leg pain, corre-
sponded to a higher daily cigarette consumption. 






























Figure 3. 95% confidence intervals for the mean total DN4 score 
by the number of cigarettes smoked daily.
Table 6. Regression model relating the DN4 score to patient characteristics
Tests of between-subjects effects
Dependent variable: DN4
Patient characteristics Sum of squares df Mean square F p
Corrected model 242.714 7 34.673 10.931 0.000
Intercept 11.681 1 11.681 3.683 0.058
Worst location 14.506 1 14.506 4.573 0.035
Most distal pain radiation 65.384 4 16.346 5.153 0.001
Fagerström score 19.579 1 19.579 6.173 0.014
STarT back total score 20.115 1 20.115 6.342 0.013
Error 355.253 112 3.172  
Total 1338.000 120   
Corrected total 597.967 119   
R Squared=0.406.
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Fagerström score were both independently associ-
ated with an increased risk for chronic LBP and ra-
dicular neuropathic pain.
Nicotine addiction
The paper by Çelik et al.[20] probably provides the 
most direct comparison to the current study. Their 
study utilized the DN4 and the Fagerström score, and 
they found that persons with a positive DN4 score 
consumed a higher number of cigarette packets per 
year compared to those who obtained a negative 
DN4 score (<0.05). Similarly, we found that the mean 
total DN4 score increased with a corresponding in-
crease in the number of cigarettes smoked daily (Fig. 
3) (p=0.002). Furthermore, Çelik et al.[20] obtained an 
OR of 1.29 (CI, 1.14–1.46) for each standard deviation 
increase (2.7) in the Fagerström score. However, re-
sults from our study show that every 1 unit increase 
in the Fagerström score yielded an OR of 1.407 (CI, 
1.095–1.809) for chronic LBP and lumbar related leg 
pain and an OR of 1.713 (CI, 1.292–2.272) for chronic 
radicular neuropathic pain. These minor differences in 
the results could be explained by the different meth-
odologies adopted to present the results (standard 
deviation increase vs. 1 unit increase in Fagerström 
score) and also by the fact that Çelik et al.[20] complied 
their OR’s with subjects having a negative DN4 score, 
yet these could still be experiencing nociceptive pain, 
while in our study comparison was made to the con-
trol group who were free from chronic pain.
Shemory et al.[38] found that nicotine dependence 
yielded a relative risk of 4.489 (p<0.001, 95% CI, 
4.471–4.506) for LBP. However, this study did not pro-
vide an insight into the relative risk of nicotine de-
pendence for developing chronic LBP, and it did not 
mention the diagnostic criteria for nicotine depen-
dence, hence hindering direct comparison and possi-
bly explaining the difference in ORs. Shaw et al.[39] ex-
amined only men with acute LBP, and they found that 
nicotine addiction leads to an increased chance for 
the chronification of LBP (OR=2.49, 95% CI, 1.15–5.40) 
among other psychological variables. However, di-
rect comparison to our study is hindered since Shaw 
et al.[39] used the Diagnostic Interview Schedule-III-R 
to asses for nicotine dependence and the subjects 
were experiencing their first LBP symptoms, while in 
our study the subjects were already suffering from 
chronic LBP. Zvolensky et al.[40] found that after adjust-
ing for various socio-demographic variables, persons 
with nicotine dependence were almost twice as likely 
to report chronic neck or back pain (OR=1.95, 95% CI, 
1.41–2.68). Besides, they found that 30% of the per-
sons suffering from past year or lifetime chronic neck 
or back pain were current smokers. However, nicotine 
dependence was assessed through the World Health 
Organization’s Composite International Diagnostic 
Interview, hence hindering direct comparison with 
our study. Overall, these three studies[38–40] provide 
higher ORs for developing LBP in subjects with nico-
tine dependence compared to our study (OR 1.407). 
However, this could be partly due to the study de-
sign, the different diagnostic criteria for nicotine de-
pendence and the way results were presented.
Smoking status
Various reviews[8–12,41,42] were conducted explor-
ing the relationship between LBP, sciatic pain, and 
smoking. However, direct comparison is hugely hin-
dered by the lack of standardization on what defines 
sciatica coupled with the lack of details regarding 
whether the neuropathic pain component was as-
sessed at all in these studies. Such broad definitions 
and diagnostic procedures will affect the inclusion 
and exclusion criteria for the respective studies and 
hence will affect the ORs. This was stressed by Cook 
et al.[11] who found “inconsistent operational defini-
tions” of what comprised sciatica raging from a med-
ical diagnosis during hospital admission to referred 
pain below the knee or a definitive or non-definitive 
area in the lower limb. All these reviews evaluated 
smoking status only, rather than concurrently ex-
amining nicotine dependence, which encapsulates 
a more extensive biopsychosocial element. In addi-
tion, certain reviews[10–12] did not assess the effect of 
smoking on chronic sciatica. Hence, the conclusion 
of the following studies must be considered in the 
light of such discrepancies.
The umbrella review by Parreira et al.[9] identified a 
systematic review by Ferreira et al.[8] (AMSTAR Grade 
6, n=1,960) evaluating chronic LBP in twin subjects. 
The latter review found that smoking was signifi-
cantly associated with LBP (pooled OR =3.0, 95% CI, 
2.8–3.3), which is very similar to our results. However, 
this twin study did not mention explicitly if their OR 
is valid for chronic LBP, but rather this review pro-
vided a pooled OR was for the most prolonged LBP 
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symptom. With regard to sciatica, the umbrella re-
view[9] identified a systematic review by Cook et al.[11] 
(AMSTAR Grade 7, n=7,701) evaluating risk factors 
for first time incidence sciatica. This review is ham-
pered by the lack of diagnostic criteria of sciatica, 
which will affect the ORs. The OR for current smoker 
ranged from 1.5 (95% CI, 1.1–2.1) to 9.6 (95% CI, 1.7–
53.0). Considering that 81.7% of our subjects were 
experiencing lumbar related leg pain, our OR (3.071) 
fits within the spectrum of ORs provided by Cook et 
al.[11] However, the standardized approach used in 
our study could provide a more reliable and repro-
ducible result.
A scoping review by Green et al.[42] identified a meta-
analysis by Shiri et al.[41] which found that a current 
smoking status yielded an OR of 1.79 (95% CI, 1.27–
2.50, n=31,811) for developing chronic LBP. Fur-
thermore, Green et al.[42] found a systematic review 
by Shiri et al.[10] assessing the association between 
smoking and lumbar radicular pain. According to 
this review, lumbar radicular pain was present in case 
of restriction in the straight leg raise test or other 
clinical signs of rhizopathy. However, this systematic 
review[10] is hindered by the lack of standardization 
and detail with regard to what clinical testing proce-
dures were used. In addition, a systematic review[43] 
has shed doubts on the diagnostic accuracy of the 
straight leg raise test in diagnosing pain originating 
from lumbar disc herniation, which can explain the 
lower OR in their study.[10]
A meta-analysis by Shiri and Falah-Hassani[12] evalu-
ated the effect of smoking on the risk of sciatica. For 
current smokers, the pooled adjusted OR was 1.64 
(95% CI, 1.24–2.16, n=10,853) for lumbar radicular 
pain, and for clinically verified sciatica the OR was 
1.35 (95% CI, 1.09–1.68, n=110,374). Furthermore, 
this meta-analysis did not provide information on 
what clinical tests were used to provide a diagnosis 
of “clinically verified sciatica,” and it only mentions 
signs of nerve root irritation, yet these can vary from 
negative sensory findings to positive ones, with neg-
ative sensory findings having a higher diagnostic 
value for the presence of neuropathic pain.[44]
Strengths and limitations of the study
The effects of a previous smoking habit can signifi-
cantly outlast the smoking free period.[11] Hence, one 
of the strengths of this study was the exclusion of 
former smokers to avoid any confounding factors af-
fecting results such as when smoking was stopped, 
any smoking cessation, and resumption of smoking 
behaviors. This study assessed nicotine dependence 
apart from solely assessing smoking status togeth-
er with the number of cigarettes consumed daily, 
henceforth addressing a possibly, treatment modifi-
able, and dimension within the biopsychosocial con-
struct of chronic LBP. To decrease bias, every effort 
was made to ensure that each patient completed all 
the questionnaires.
This study had to overcome the inherent difficulties 
in quantifying sciatica. Sciatica can originate both 
from neuropathic and nociceptive pain, yet these 
cannot be properly quantified without a standard 
examination. Most of the cited papers[9–12,42] report-
ed that a clinical examination was conducted, yet 
specific details of such examination were not men-
tioned, hence hindering reproducibility. Besides, 
most of the cited studies gave prime importance to 
the pain experience, rather than to other neurologi-
cal manifestations such as hypoesthesia, myotomal 
weakness, or alterations in tendon reflexes. Diag-
nosing neuropathic pain is essential as neuropathic 
pain tends to lower the quality of life to a greater 
degree compared to nociceptive pain.[6] Hence, the 
importance of the DN4 as a validated diagnostic 
neuropathic pain questionnaire to differentiate be-
tween sciatic pain with a distinct neuropathic pain 
component from sciatica with a nociceptive pain 
component only. This offers standardization, hence 
facilitating the comparison of results between sub-
jects and any future studies. Another strength of 
this study was that the population was a specific 
patient subgroup with chronic LBP, with or with-
out radicular neuropathic leg pain. Nonetheless, 
this poses challenges on the generalizability of the 
results to acute, subacute LBP, and to other neuro-
pathic pain conditions and may be considered as a 
limitation of this study.
A limitation was the significant element of recall bias 
when current smokers in both chronic pain and con-
trol groups were asked when they had started smok-
ing, which most could not recall exactly. More than 
75% of the subjects in both groups reported a his-
tory of at least 15 years of smoking, with fluctuations 
in the number of cigarettes smoked daily. Despite 
the dose-response analysis carried out in this paper, 
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the temporal aspects of daily cigarette consumption 
could influence the symptomatology and possibly af-
fect the conclusion of this study. Selection bias could 
have arisen since the patients were referred from the 
main general hospital to the physiotherapy outpa-
tients department. The patient cohort was mixed in 
nature with the majority of the participants having 
already undergone unsuccessful medical treatment 
and hence represents a more refractory cohort of 
chronic LBP patients, while for others, it was their 
first attempt at managing their chronic LBP. The sub-
jects were not randomized, but it was a consecutive 
sample of eligible subjects. However, such selection 
bias was beyond the authors’ control. Nonetheless, 
the chronic pain group was representative of the 
principal investigator’s yearly clinical caseload.
Future research, using longitudinal studies, could in-
vestigate after how many months or years of smoking 
cessation, the heightened risk of developing chronic 
LBP and neuropathic radicular leg pain decreases. 
The use of validated neuropathic pain diagnostic 
tools is encouraged to facilitate standardization and 
study reproducibility. Besides, considering the sig-
nificant difference in the DN4 Interview subscore be-
tween current smokers and non-smokers (p=0.000), 
it would be interesting for future research to asses 
if specific psychological constructs mediate the as-
sociation between neuropathic pain dysesthesias 
specifically in current smokers, for example, anxiety, 
depression, stress, pain self-efficacy, pain coping, 
or catastrophizing, through the use of appropriate 
measures, which due to the time constraints of the 
clinical assessment within the current study was not 
doable. This can shed light on the psychobiology un-
derlying neuropathic pain in smokers.
Conclusion
This study shows that current smokers and a higher 
nicotine dependency were both independently as-
sociated with a higher odds ratio for the presence of 
chronic LBP, lumbar related leg pain, and chronic ra-
dicular neuropathic leg pain. This may have implica-
tions on treatment effect and patient outcomes.
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